{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Degenerative+Conditions%2C+Neurologic&page=32", "query": { "condition": "Degenerative Conditions, Neurologic", "page": 32 }, "page_size": 10 }, "pagination": { "page": 32, "page_size": 10, "total_count": 5558, "total_pages": 556, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Degenerative+Conditions%2C+Neurologic&page=33&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Degenerative+Conditions%2C+Neurologic&page=31&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-15T21:33:55.764Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02002819", "title": "Levetiracetam for Alzheimer's Disease-Associated Network Hyperexcitability", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Alzheimer's Disease" ], "interventions": [ { "name": "levetiracetam", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "45 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "45 Years to 80 Years" }, "enrollment_count": 34, "start_date": "2014-10-16", "completion_date": "2020-07-21", "has_results": true, "last_update_posted_date": "2022-05-16", "last_synced_at": "2026-10-15T21:33:55.764Z", "location_count": 2, "location_summary": "San Francisco, California • Minneapolis, Minnesota", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT02002819" }, { "nct_id": "NCT05864157", "title": "Targeted Motor Learning to Improve Gait for Individuals With Parkinson Disease", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Parkinson Disease" ], "interventions": [ { "name": "Gait training without rhythmic auditory cues", "type": "OTHER" }, { "name": "TRAC", "type": "OTHER" }, { "name": "dTRAC", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of North Carolina, Chapel Hill", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "50 Years to 80 Years" }, "enrollment_count": 45, "start_date": "2023-08-16", "completion_date": "2027-01-01", "has_results": false, "last_update_posted_date": "2026-06-25", "last_synced_at": "2026-10-15T21:33:55.764Z", "location_count": 1, "location_summary": "Chapel Hill, North Carolina", "locations": [ { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT05864157" }, { "nct_id": "NCT00479401", "title": "Efficacy, Safety, Tolerability of Pramipexol ER Versus Pramipexol IR Versus Placebo in Early PD Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Early Parkinson Disease (Early PD)" ], "interventions": [ { "name": "Pramipexol Extended Release", "type": "DRUG" }, { "name": "Pramipexol Immediate Release", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": null, "sex": "ALL", "summary": "30 Years and older" }, "enrollment_count": 539, "start_date": "2007-05", "completion_date": null, "has_results": true, "last_update_posted_date": "2014-07-17", "last_synced_at": "2026-10-15T21:33:55.764Z", "location_count": 16, "location_summary": "Gilbert, Arizona • Sun City, Arizona • La Jolla, California + 13 more", "locations": [ { "city": "Gilbert", "state": "Arizona" }, { "city": "Sun City", "state": "Arizona" }, { "city": "La Jolla", "state": "California" }, { "city": "Oxnard", "state": "California" }, { "city": "Danbury", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT00479401" }, { "nct_id": "NCT03449212", "title": "SOD1 Kinetics Measurements in ALS Patients", "overall_status": "SUSPENDED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Amyotrophic Lateral Sclerosis, Familial", "Amyotrophic Lateral Sclerosis, Sporadic" ], "interventions": [], "intervention_types": [], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 86, "start_date": "2012-12", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2024-07-25", "last_synced_at": "2026-10-15T21:33:55.764Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT03449212" }, { "nct_id": "NCT07824128", "title": "Adaptango Performance PRocess for Older Adults Community reHabilitation", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Parkinson Disease", "Mild Cognitive Impairment", "Old Age; Dementia" ], "interventions": [ { "name": "Adaptango Performance Process (APP) program", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 120, "start_date": "2026-10", "completion_date": "2029-09", "has_results": false, "last_update_posted_date": "2026-09-17", "last_synced_at": "2026-10-15T21:33:55.764Z", "location_count": 1, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT07824128" }, { "nct_id": "NCT04855630", "title": "Combating Alzheimer's Through Sleep and Exercise", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Dementia", "Mild Cognitive Impairment (MCI)", "Cognitively Unimpaired", "Alzheimer's Dementia (AD)" ], "interventions": [ { "name": "Elemind Neuromodulation Headband", "type": "DEVICE" }, { "name": "Exercise Routine", "type": "OTHER" } ], "intervention_types": [ "DEVICE", "OTHER" ], "sponsor": "University of Miami", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "55 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "55 Years to 80 Years" }, "enrollment_count": 60, "start_date": "2023-03-01", "completion_date": "2028-12-30", "has_results": false, "last_update_posted_date": "2026-09-23", "last_synced_at": "2026-10-15T21:33:55.764Z", "location_count": 1, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04855630" }, { "nct_id": "NCT06442033", "title": "Genetics and Aerobic Exercise to Slow Parkinson's Disease Trial", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Parkinson Disease" ], "interventions": [ { "name": "High intensity stationary cycling", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Jay Alberts", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 200, "start_date": "2024-08-23", "completion_date": "2028-12-31", "has_results": false, "last_update_posted_date": "2026-08-21", "last_synced_at": "2026-10-15T21:33:55.764Z", "location_count": 1, "location_summary": "Cleveland, Ohio", "locations": [ { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT06442033" }, { "nct_id": "NCT04784416", "title": "Transcranial Photobiomodulation for Alzheimer's Disease (TRAP-AD)", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Mild Cognitive Impairment", "Alzheimer Disease" ], "interventions": [ { "name": "Active tPBM-2.0", "type": "DEVICE" }, { "name": "Sham tPBM-2.0", "type": "DEVICE" }, { "name": "18F-MK-6240", "type": "DRUG" } ], "intervention_types": [ "DEVICE", "DRUG" ], "sponsor": "NYU Langone Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "65 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "65 Years to 85 Years" }, "enrollment_count": 196, "start_date": "2021-04-27", "completion_date": "2026-01-31", "has_results": false, "last_update_posted_date": "2025-12-09", "last_synced_at": "2026-10-15T21:33:55.764Z", "location_count": 3, "location_summary": "Boston, Massachusetts • New York, New York • Orangeburg, New York", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "New York", "state": "New York" }, { "city": "Orangeburg", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04784416" }, { "nct_id": "NCT01689233", "title": "Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Alzheimer's Disease" ], "interventions": [ { "name": "TRx0237 200 mg/day", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "TauRx Therapeutics Ltd", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "89 Years", "sex": "ALL", "summary": "Up to 89 Years" }, "enrollment_count": 800, "start_date": "2012-10", "completion_date": "2016-05", "has_results": false, "last_update_posted_date": "2018-03-14", "last_synced_at": "2026-10-15T21:33:55.764Z", "location_count": 58, "location_summary": "Phoenix, Arizona • Bellflower, California • Costa Mesa, California + 53 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Bellflower", "state": "California" }, { "city": "Costa Mesa", "state": "California" }, { "city": "Fountain Valley", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01689233" }, { "nct_id": "NCT03539952", "title": "Trientine Tetrahydrochloride (TETA 4HCL) for the Treatment of Wilson's Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Wilson Disease" ], "interventions": [ { "name": "Penicillamine (D1-W12)", "type": "DRUG" }, { "name": "TETA 4HCL (W12-60)", "type": "DRUG" }, { "name": "Penicillamine (W12-W60)", "type": "DRUG" }, { "name": "TETA 4HCL (60-